Anna W. Byars

Anna W. Byars

Auto-generated profile, based on publicly available information

Anna W. Byars

Division of Neurology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 September 2023 in Journal of Neurodevelopmental Disorders
Verified
Journal Article
Open access
PDF file
PVPetrus J de Vries
Petrus J de Vries
THTosca-Marie Heunis
Tosca-Marie Heunis
SVStephanie Vanclooster
Stephanie Vanclooster
NCNola Chambers
Nola Chambers
SBStacey Bissell
Stacey Bissell
AJAnna C. Jansen
Anna C. Jansen
Background: Tuberous sclerosis complex (TSC) is associated with a wide range of physical manifestations for which international clinical recommendations for diagnosis and management have been established. TSC is, however, also associated with a wide range of TSC-Associated Neuropsychiatric Disorders (TAND) that are typically under-identified and under-treated yet associated with a profound burden of disease. The contemporary evidence base for the identification and treatment of TAND is much more limited and, to date, consensus recommendations for the diagnosis and management of TAND have also been limited and non-specific. Methods: The TANDem project was launched with an international, interdisciplinary, and participatory consortium of 24 individuals, including TSC family representatives, from all World Health Organization (WHO) regions but one. One of the aims of the TANDem project was to generate consensus recommendations for the identification and treatment of TAND. At the time of this project, no internationally adopted standard methodology and methodological checklists existed for the generation of clinical practice recommendations. We therefore developed our own systematic procedure for evidence review and consensus-building to generate evidence-informed consensus recommendations of relevance to the global TSC community. Results: At the heart of the consensus recommendations are ten core principles surrounded by cluster-specific recommendations for each of the seven natural TAND clusters identified in the literature (autism-like, dysregulated behavior, eat/sleep, mood/anxiety, neuropsychological, overactive/impulsive, and scholastic) and a set of wraparound psychosocial cluster recommendations. The overarching recommendation is to “screen” for TAND at least annually, to “act” using appropriate next steps for evaluation and treatment, and to “repeat” the process to ensure early identification and early intervention with the most appropriate biological, psychological, and social evidence-informed approaches to support individuals with TSC and their families. Conclusions: The consensus recommendations should provide a systematic framework to approach the identification and treatment of TAND for health, educational, social care teams and families who live with TSC. To ensure global dissemination and implementation of these recommendations, partnerships with the international TSC community will be important. One of these steps will include the generation of a “TAND toolkit” of “what to seek” and “what to do” when difficulties are identified in TAND clusters.

7 July 2023 in Pediatric Neurology
Verified
Journal Article
Open access
THTosca-Marie Heunis
Tosca-Marie Heunis
NCNola Chambers
Nola Chambers
SVStephanie Vanclooster
Stephanie Vanclooster
SBStacey Bissell
Stacey Bissell
ABAnna W. Byars
Anna W. Byars
PVPetrus J de Vries
Petrus J de Vries
Tuberous sclerosis complex-associated neuropsychiatric disorders (TAND) are often present but underidentified and undertreated in individuals with tuberous sclerosis complex (TSC). The clinician-completed TAND-Lifetime Checklist (TAND-L) was developed to address this identification and treatment gap. Stakeholder engagement identified the need for a TAND Checklist that can (1) be completed by caregivers or individuals with TSC and (2) quantify TAND difficulties. The aim of this study was to develop a self-report quantified TAND Checklist (TAND-SQ) and conduct feasibility and acceptability testing. This aim was addressed in three phases: (1) development of the TAND-SQ Checklist, (2) feasibility and acceptability testing of the "near-final" TAND-SQ Checklist, and (3) preparation of the final TAND-SQ Checklist. Participants included 23 technical experts from the TAND consortium in all phases and 58 lived experts (caregivers and individuals with TSC) in phase 2. All participants completed a TAND-SQ Checklist and a checklist feedback form. Phase 1 additions to the TAND-SQ, when compared with the TAND-L, included four new items and a quantification rating. Phase 2 showed high ratings for the "near-final" TAND-SQ Checklist on comprehensiveness, clarity, ease of use, and overall acceptability. In phase 3, questions on strengths, strategies, and a TAND Cluster Profile were added. The TAND-SQ Checklist is presented here for use by individuals with TSC and their caregivers. The next steps as part of the TANDem project include internal and external validation of the checklist and linking of TAND Cluster Profiles generated from the checklist to evidence-informed consensus recommendations within a smartphone application.

13 June 2025 in Orphanet Journal of Rare Diseases
Verified
Journal Article
Open access
PDF file
NCNola Chambers
Nola Chambers
THTosca-Marie Heunis
Tosca-Marie Heunis
SGSugnet Gardner-Lubbe
Sugnet Gardner-Lubbe
JCJamie K. Capal
Jamie K. Capal
SBStacey Bissell
Stacey Bissell
PVPetrus J de Vries
Petrus J de Vries
Background: Tuberous Sclerosis Complex (TSC) is a rare multi-system genetic disorder characterised by benign growths in multiple body systems. TSC-Associated Neuropsychiatric Disorders (TAND) are very common in individuals with TSC, but families often struggle to access appropriate clinical care. To address this gap, the new TAND-SQ Checklist allows individuals with TSC or their caregivers to self-report and quantify characteristics of TAND. The 33 items make up seven natural TAND clusters and an eighth cluster reflecting psychosocial difficulties in individuals with TSC and their caregivers. Respondents rate items as having ever been present to generate cluster scores (CS), and rate item severity (over the last month) on a 10-point scale to generate cluster severity scores (CSSmean) and a total TAND severity score (TTSSmean). The purpose of this study was to determine the reliability and validity of the CS, CSSmean and TTSSmean of the TAND-SQ. Methods: A descriptive group design was used. Two convenience samples with existing clinical data were recruited from the TSC Alliance Natural History Database (NHD) in the USA (n = 69), and from the Developmental Synaptopathies Consortium Rare Diseases Clinical Research Network (RDCRN) study based at Boston and Cincinnati Children's Hospitals (n = 23), totalling 92 participants. Results: Analyses showed good internal consistency for CS (Cronbach’s alphas: 0.67–0.89) and CSSmean (0.76–0.95) with the exception of the eat/sleep cluster. Within the TAND-SQ, most CS and all CSSmean were significantly correlated to corresponding self-reported clinical diagnoses, and the TTSSmean was significantly correlated to a global self-rating of TAND burden (ρ = 0.75; p < .001). Significant correlations were observed between the CS and CSSmean and a range of relevant standardised behavioural measures in the RDCRN cohort. The TTSSmean was significantly correlated with global measures of adaptive behaviour (ρ = − 0.75; p < .001) and emotional/behavioural difficulties (ρ = 0.71; p = .001). All CS were significantly correlated with corresponding diagnoses of autism, ADHD, anxiety disorder, depressive disorder, scholastic difficulties, and neuropsychological difficulties where reported in the RDCRN and NHD cohorts. Conclusions: Findings provide support for the reliability and validity of the CS, CSSmean and TTSSmean of the TAND-SQ and support their use in clinical decision-making for TAND management and in further research.

30 July 2010 in Science
Verified
Journal Article
Closed access
PDF file
SHScott K Holland
Scott K Holland
ABAnna W Byars
Anna W Byars
EPElena Plante
Elena Plante
JSJerzy P Szaflarski
Jerzy P Szaflarski
KDKim Dietrich
Kim Dietrich
MAMekibib Altaye
Mekibib Altaye

5 May 2026 in JMIR Research Protocols
Verified
Journal Article
Open access
PVPetrus J de Vries
Petrus J de Vries
NCNola Chambers
Nola Chambers
ECErin Campbell
Erin Campbell
LGLucas Gutierrez-Lafrentz
Lucas Gutierrez-Lafrentz
THTosca-Marie Heunis
Tosca-Marie Heunis
AJAnna C Jansen
Anna C Jansen
Background: Tuberous sclerosis complex (TSC) is a rare genetic disorder caused by pathogenic variants in the TSC1 or TSC2 genes. Apart from multisystem physical manifestations, most individuals with TSC experience TSC-associated neuropsychiatric disorders (TAND). Little is known about how TAND severity changes over time and what factors may predict these changes. Preliminary data suggest the presence of differential TAND severity trajectories. Caregiver well-being may act as a mediator of TAND severity, and a well-being intervention designed for caregivers of children with developmental disabilities may improve caregiver well-being. Objective: The study aims are to (1) examine longitudinal trajectories of TAND severity in a large sample of individuals with TSC and to examine potential predictors of differential trajectories, (2) evaluate the association between caregiver well-being characteristics, TAND severity, and severity trajectories, and (3) adapt and evaluate the feasibility, acceptability, and potential efficacy of a brief, online group–based well-being intervention for family caregivers. Methods: For the first 2 aims, 500 individuals with TSC or their caregivers will be recruited in an accelerated longitudinal design to document TAND severity at 5 time points over 12 months via a web-based app. At each time point, participants will complete demographic, TSC characteristics, intervention, and well-being questionnaires. Data will be analyzed using latent class mixed and multinomial regression modeling (aim 1) and structural equation and mediation modeling (aim 2). Participatory methods will be used to adapt an existing caregiver well-being intervention for the TSC community (aim 3). Thirty caregivers will be invited to participate in the adapted group-based online well-being intervention. Results: This study was funded from July 2024 (HT94252410790 and HT94252410791), and ethics approvals were obtained from the University of Cape Town (July 2024), Vrije Universiteit Brussel (November 2024), and the Department of Defense Office of Human Research Oversight (December 2024). The TAND Toolkit app was adapted for longitudinal data collection (aims 1 and 2). Recruitment started in December 2025 and will continue until 500 participants are enrolled (anticipated December 2026). Primary outputs are expected by July 2028. For aim 3, experiential and adaptation workshops were completed in June 2025, the pilot intervention was delivered in November 2025, and data collection will continue till May 2026. Outputs are expected by December 2026. Conclusions: Identification of differential longitudinal TAND trajectories and their correlates will stimulate research in TSC and generate evidence for the self-report quantified TAND checklist as a clinical outcome measure. Understanding the association between caregiver well-being and TAND severity will provide support for targeted well-being interventions. A successful pilot trial will provide preliminary data for larger-scale clinical trials, with the potential to support caregivers and improve TAND outcomes. Together, the findings from the study will help close the gap in interventions for TAND. Trial Registration: ClinicalTrials.gov NCT06879665; https://clinicaltrials.gov/study/NCT06879665 International Registered Report Identifier (IRRID): DERR1-10.2196/91726

4 April 2026 in Epilepsia
Verified
Journal Article
Open access
BEBrian Ervin
Brian Ervin
JBJason Buroker
Jason Buroker
TCTaylor Cummins
Taylor Cummins
ABAnna W. Byars
Anna W. Byars
CSCraig Scholle
Craig Scholle
RARavindra Arya
Ravindra Arya
Objective: We describe a safe, informative, and easy‐to‐implement approach for presurgical mapping of visual working memory (VWM) with stereo‐electroencephalography (SEEG). Methods: Twenty‐four patients with drug‐resistant epilepsy, 11–23 years of age, performed a single‐probe change detection VWM task, during SEEG monitoring. High‐gamma modulations (HGMs) and connectivity modulations (weighted phase lag index) were computed for encoding, retention, recall, and response phases compared to a rest phase. Effects of lesioning sites with significant HGM on neuropsychological outcomes were analyzed. Results: Validity of our VWM task was evident by picture vocabulary scores covarying positively with increasing consistency and negatively with increasing maximum latency of the response times, respectively. VWM task elicited specific patterns of cortical HGMs during each phase: bilateral frontoparietal augmentation during encoding, replaced by widespread suppression during retention, followed by diffuse bilateral augmentation during the recall and response phases. Distinct neural circuits were also observed during each phase of the VWM task: left‐lateralized phonological loop during encoding, short‐range bilateral frontal connectivity during retention, and interhemispheric peri‐Rolandic hubs during recall and response phases. Lesioning sites with significant high‐gamma augmentation was associated with declines in domains directly relevant to VWM including working memory (slope −6.18, p < .001), visuospatial (−1.17, p = .031), picture vocabulary (−1.45, p < .001), and letter‐word identification (−6.39, p = .004), whereas lesioning sites with significant high‐gamma suppression, particularly in recall and response phases, affected domains sharing resources for neural computations with working memory, but not directly related to VWM including processing speed (−16.04, p = .049), calculation (−19.12, p = .020), and verbal comprehension (−9.09, p = .020). Significance: Our observations extend theoretical models of VWM by providing phase‐specific engagement of neural subsystems, particularly of phonological loop during encoding of even visually‐cued stimuli and spatial rehearsal mechanisms during retention. Clinically, adverse neuropsychological outcomes from lesioning of VWM sites during epilepsy surgery support wider adoption of VWM mapping during presurgical evaluation of patients with drug‐resistant epilepsy.